Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Persistent Postoperative Pain × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8827 Neoplasms 6774 Carcinoma, Non-Small-Cell Lung 4950 Prostatic Neoplasms 4374 Colorectal Neoplasms 3963 Lung Neoplasms 3208 Leukemia, Myeloid, Acute 2685 Neoplasm Metastasis 2676 Multiple Myeloma 2656 Pancreatic Neoplasms 2476 Melanoma 2293 Lymphoma 2240 Ovarian Neoplasms 2235 Carcinoma, Hepatocellular 2140 Stomach Neoplasms 2020 Recurrence 1917 Head and Neck Neoplasms 1818 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1800 Lymphoma, Non-Hodgkin 1778 Leukemia 1772 Brain Neoplasms 1682 Glioblastoma 1573 Colonic Neoplasms 1545 Leukemia, Lymphocytic, Chronic, B-Cell 1521 Rectal Neoplasms 1498 Uterine Cervical Neoplasms 1441 Squamous Cell Carcinoma of Head and Neck 1414 Lymphoma, Follicular 1406 Lymphoma, Large B-Cell, Diffuse 1374 Carcinoma, Renal Cell 1358

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03216187 2025-10-07

PREVENT

University Hospital, Geneva

Phase 3 Terminated

Persistent Postoperative Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡